GF-AMY 5mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of GF-AMY supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-AMY5-B241

Key analytical results include:

• Assay Content: 4.52 mg
• Identification – Retention Time: 0.996
• Identification – Spectrum: 997
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

GF-AMY is a long-acting peptide research compound studied in controlled laboratory environments focused on metabolic signalling pathways and peptide-mediated regulatory systems.

The compound belongs to a class of extended-activity peptide analogues investigated in biochemical research for their interaction with metabolic regulatory signalling networks.

This preparation contains 5 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, GF-AMY has become a frequently referenced compound in experimental metabolic research models.

Compound Overview

GF-AMY is a synthetic peptide analogue designed for research purposes, studied in biochemical settings for its interaction with receptor-mediated signalling systems.

Within experimental models, the compound is commonly investigated for its interaction with peptide receptor pathways and related regulatory signalling systems.

Due to its defined molecular structure and receptor interaction profile, the compound is frequently used in laboratory studies examining peptide-mediated metabolic regulation and signalling networks.

Historical Background and Scientific Context

Scientific interest in peptide-based metabolic regulators expanded during the late twentieth century as researchers began identifying hormones involved in energy balance and signalling processes.

This led to the development of synthetic peptide analogues that could be studied under controlled laboratory conditions to better understand receptor interactions and signalling pathways.

These developments enabled researchers to investigate peptide-receptor dynamics and metabolic signalling mechanisms in highly controlled experimental environments.

Mechanistic Focus in Research

Within experimental laboratory settings, GF-AMY is commonly studied in relation to peptide-mediated metabolic signalling pathways.

Research investigations commonly explore the compound in experimental models examining:

• Peptide receptor signalling pathways
• Metabolic regulatory networks
• Peptide receptor interaction dynamics
• Intracellular signalling mechanisms
• Comparative metabolic peptide research
• Molecular signalling pathway analysis
• Regulatory peptide interaction modelling

These experimental models allow scientists to investigate molecular mechanisms involved in metabolic signalling and peptide-mediated regulatory processes.

Research Applications

In controlled research environments, GF-AMY may be utilised in experimental models designed to explore metabolic signalling systems and peptide receptor interactions.

Examples of research applications include:

• Metabolic pathway investigation
• Peptide receptor interaction research
• Intracellular signalling network modelling
• Comparative peptide compound studies
• Molecular regulatory pathway analysis
• Metabolic signalling research
• Controlled in vitro metabolic studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.8 % purity confirmed by COA
• Assay content verified at 4.52 mg
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• High-purity research peptide for controlled laboratory use
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.